Alteogen, Inc.

ISIN KR7196170005

 | 

WKN A14QY9

Market cap (in EUR)
11,662.27 m
Country
South Korea
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Alteogen, Inc. engages in the development, manufacture, and sale of biopharmaceuticals and anticancer drugs. Its products include technologies for anti-breast cancer drug and biosimilar, technology consulting, and other services. The company was founded on May 13, 2008 and is headquartered in Daejeon, South Korea.
Show more Show less
Healthcare Biopharmaceuticals Other Biopharmaceuticals South Korea

Financials

Key metrics

Market capitalisation, EUR 11,662.27 m
EPS, EUR 0.79
P/B ratio 67.20
P/E ratio 294.36
Dividend yield 0.00%

Income statement (2024)

Revenue, EUR 69.78 m
Net income, EUR 42.24 m
Profit margin 60.52%

What ETF is Alteogen, Inc. in?

There are 74 ETFs which contain Alteogen, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Alteogen, Inc. is the HSBC MSCI Korea Capped UCITS ETF USD.

Order fees

Here you can find information about different brokers that allow you to trade stocks. Select your preferred order volume to compare the fees charged by the respective brokers.
 
Broker Rating Order fee Stock savings plans
0.99€
1000
View offer*
1.00€
2500
View offer*
0.00€
2500
View offer*
0.00€
1200
View offer*
0.00€
500
View offer*
Show all offers
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Order fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.